Previous 10 | Next 10 |
AzurRx BioPharma (NASDAQ: AZRX) , a clinical stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases, has shared a letter to shareholders from chair, president and CEO James Sapirstein. T...
AzurRx BioPharma ([[AZRX]] -7.8%) has entered into an agreement with global contract research organization PPD < > for its planned Phase 1b/2a clinical trial evaluating proprietary formulations of micronized niclosamide for grade 1 colitis and diarrhea in oncology patie...
DELRAY BEACH, Fla., April 13, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestina...
A group of researchers from the Feinberg School of Medicine at Northwestern University has discovered additional evidence of cognitive dysfunction in many coronavirus patients who were not hospitalized after contracting the infection. The group’s findings were reported in the ȁ...
“RESERVOIR” trial to evaluate niclosamide’s ability to target SARS-CoV-2 in the GI tract Topline data expected in Q1 2022 DELRAY BEACH, Fla., April 06, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the ...
Gainers: AeroCentury (ACY) +235%.Liberty TripAdvisor (LTRPB) +106%.Uxin (UXIN) +53%.Universe Pharmaceuticals (UPC) +36%.Applied Molecular Transport (AMTI) +31%.Euro Tech Holdings (CLWT) +26%.PLBY Group (PLBY) +25%.Nuvve (NVVE) +24%.Moxian (MOXC) +18%.Sonoma Pharmaceuticals (SNOA) +1...
Gainers: Universe Pharmaceuticals UPC +50%, Applied Molecular Transport AMTI +26%, Sonoma Pharmaceuticals (SNOA) +17%, United Therapeutics UTHR +16%, PAVmed (PAVM) +12%.Losers: AzurRx BioPharma (AZRX) -28%, BioXcel Therapeutics (BTAI) -14%,...
AzurRx BioPharma (AZRX) -29% after MS1819 fails in mid-stage cystic fibrosis study.XpresSpa Group (XSPA) -15% on Q4 earnings release.CTI BioPharma (CTIC) -12% after secures $51M capital raise.MicroVision (MVIS) -12%.Boston Omaha (BOMN) -10% on pricing p...
DELRAY BEACH, Fla., March 31, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestina...
DELRAY BEACH, Fla., March 31, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestina...
News, Short Squeeze, Breakout and More Instantly...
AzurRx BioPharma Inc. Company Name:
AZRX Stock Symbol:
NASDAQ Market:
AzurRx BioPharma Inc. Website:
BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (G...
Why Investors Are Watching These 3 Penny Stocks Right Now There are plenty of ways to find the best penny stocks to buy right now. And, one method that many penny stocks investors use is looking at what top investors are buying alongside other metrics. While this can be a good strat...
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastroint...